0001209191-19-055411.txt : 20191105 0001209191-19-055411.hdr.sgml : 20191105 20191105212839 ACCESSION NUMBER: 0001209191-19-055411 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191024 FILED AS OF DATE: 20191105 DATE AS OF CHANGE: 20191105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Peck Bill CENTRAL INDEX KEY: 0001756137 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38720 FILM NUMBER: 191194893 MAIL ADDRESS: STREET 1: C/O TWIST BIOSCIENCE CORPORATION STREET 2: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Twist Bioscience Corp CENTRAL INDEX KEY: 0001581280 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462058888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH, SUITE 5 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 800-719-0671 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH, SUITE 5 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-24 1 0001581280 Twist Bioscience Corp TWST 0001756137 Peck Bill C/O TWIST BIOSCIENCE CORPORATION 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 0 1 0 0 Chief Technology Officer Common Stock 2019-10-24 4 A 0 2780 0.00 A 666112 D Common Stock 2019-11-01 4 D 0 4363 24.4286 D 661749 D Common Stock 2019-11-01 4 D 0 15637 25.0985 D 646112 D Employee Stock Option (right to buy) 23.33 2019-10-24 4 A 0 11910 0.00 A 2029-10-23 Common Stock 11910 11910 D Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 25% of the shares subject to the RSU Award vesting on October 24, 2020 and 1/16th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. The transactions reported on this row were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Represents the aggregate of sales effected on the same day at different prices. Represents the weighted average sales price per share. The shares sold at prices ranging from $23.81 to $24.805 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Represents the weighted average sales price per share. The shares sold at prices ranging from $24.82 to $25.395 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. 25% of the shares subject to the option vest and become exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuing service through each vesting date. /s/ William Solis, as Attorney-in-Fact for Bill Peck 2019-11-05